BPA Studies To Continue Under FDA: Agency Faulted For Ignoring Data On Plastics' Health Risks

BPA Studies To Continue Under FDA: Agency Faulted For Ignoring Data On Plastics' Health Risks

The Food and Drug Administration, criticized by its own scientific advisers for ignoring available data about health risks posed by a chemical found in everyday plastic, said yesterday it has no plans to amend its position on the substance but will continue to study it.

The agency has been reviewing its risk assessments for bisphenol A, a chemical used to harden plastic that is found in a wide variety of products, from baby bottles to compact discs to the lining of canned goods. The chemical, commonly called BPA, mimics estrogen and may disrupt the body's carefully calibrated endocrine system.

Popular in the Community

Close

What's Hot